Inside the Lab Oncology, Microbiology and immunology, Precision medicine

Current and Emerging Biomarkers in Immuno-Oncology

Pathologists play a crucial role in furthering advancements that may help predict which patients are likely to benefit from immuno-oncology therapies.

09/07/2019

sponsored by Bristol-Myers Squibb

This webinar will empower you to understand the biology behind current and emerging immuno-oncology biomarkers.

Learning Objectives of Webinar

Gain better understanding of current and emerging I-O biomarkers and how they can be assessed in clinical practice

Review of the immune system and cancer
Current and Emerging predictive I-O biomarkers
Biomarker testing practicalities

View on demand

Visit our Webinar Hub

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the Retina field I want to stay up to date with the Infectious Diseases field I want to stay up to date with the Pathologist Educator field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.